Study of how your body processes natural inflammation signals
Part of Hormones & metabolism clinical trials.
This early study looks at how the body breaks down certain natural inflammation-related chemicals (“eicosanoids”). It aims to understand normal metabolism pathways, and you may help by sharing how your body responds while you avoid certain medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy person (not a person with an illness being treated in the study).
- You should not be taking any medications right now.
- Do not take anti-inflammatory or over-the-counter pain medicines (like NSAIDs) within the last 2 weeks.
- You likely need to have been off these medicines for at least 2 weeks before starting.
- Be able to follow the study’s medication-avoidance rules during screening.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how your body naturally resolves inflammation, which is important for heart health and conditions like diabetes. It involves blood draws and tests to understand how inflammation works.
This study checks how your immune system (your body’s defense system) reacts to a controlled substance that triggers inflammation. It may help researchers understand why some people have stronger or weaker inflammatory responses.
This study looks at how certain fats (called bioactive lipids) relate to immune cells in healthy people. By comparing people with and without inflammation, researchers hope to understand how these lipids might help detect or treat inflammatory conditions.
This is an observational study that follows generally healthy adults to understand how inflammation, diabetes (type 2), and weight/metabolic health relate to each other. It may help researchers figure out why different groups (including different ethnic backgrounds) have different health risks.
This study tests how three different anti-inflammatory drugs (dexamethasone, tocilizumab, and anakinra) affect the body's immune response during a controlled, short-term inflammation. It is for healthy young men who can safely receive an experimental substance that temporarily mimics an infection.
This trial studies tiny gene-like signals (microRNAs) to understand and reduce long-term inflammation as people get older. It may help researchers learn how aging affects inflammation and could guide future treatments.
Hear when a new Metabolism of Prostaglandin D2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.